MONTROSE CAPITAL PARTNERS

Mark Tompkins Montrose Capital investment fund is organized as open investment funds that is a separate property without legal entity whose shareholders are entitled to a proportional part of the income of the Montrose Capital at any time have the right to require payment of shares that will withdraw from it. Open Investment Fund, or separate property without legal entity composed of joint funds collected by issuing a public sale of shares of the Mark Tompkins Montrose Capital, as well as proper... ty acquired by the investment of these funds, including income and rights arising from such property. Investment funds are a great opportunity for venture capital, where investors have entrusted their funds and specialized institutions - fund management investment funds. The money collected through the sale of shares in the Mark Tompkins Montrose Capital, and the company will invest the same in accordance with the provisions of law, the Prospectus and the Articles of Incorporation. The Fund is owned by the holders. Owners of shares entitled to a proportional part of the income of the Fund, as at any time to require payment of the and thus withdraw from the fund. Investors in the fund may be domestic and / or foreign, physical and / or legal entities. The investment objective of Mark Tompkins Montrose Capital is to increase the value of the property, achieving steady growth in the value of the share and the high level of security for investment. For the realization of the investment objective, the Mark Tompkins intends to invest the assets of Montrose Capital primarily in market instruments money (deposits) and low-risk portfolio of debt securities. In the process of asset management company will implement its huge experience with tradition of safe and conservative investment process.
MONTROSE CAPITAL PARTNERS
Industry:
Finance Financial Services Impact Investing
Founded:
2001-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail ReCAPTCHA
Similar Organizations
Global Founders Capital
GFC is a globally oriented, stage agnostic venture fund that empowers gifted entrepreneurs.
Time Ventures
Time Ventures supports passionate projects with early-stage funding and consulting services.
Current Employees Featured
Mark Tompkins Board member @ Montrose Capital Partners
Board member
2011-04-06
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-06-16 | Amesite | Amesite acquired by Montrose Capital Partners | 5.5 M USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-07-01 | Compass Therapeutics, Inc. | Montrose Capital Partners investment in Venture Round - Compass Therapeutics, Inc. | 60.48 M USD |
2019-07-03 | Odyssey Semiconductor Technologies | Montrose Capital Partners investment in Venture Round - Odyssey Semiconductor Technologies | 2.5 M USD |
2017-03-16 | Aerpio Pharmaceuticals | Montrose Capital Partners investment in Venture Round - Aerpio Pharmaceuticals | 40 M USD |
2016-06-08 | Miramar Labs | Montrose Capital Partners investment in Venture Round - Miramar Labs | N/A |
2016-05-04 | Valeritas | Montrose Capital Partners investment in Venture Round - Valeritas | N/A |
2016-02-01 | Bizly | Montrose Capital Partners investment in Pre Seed Round - Bizly | 1.5 M USD |
2015-07-24 | ViewRay | Montrose Capital Partners investment in Post-IPO Equity - ViewRay | 26.7 M USD |
2015-05-26 | Akoustis | Montrose Capital Partners investment in Post-IPO Equity - Akoustis | 5.3 M USD |
2014-12-23 | Pieris Pharmaceuticals | Montrose Capital Partners investment in Post-IPO Equity - Pieris Pharmaceuticals | 13.6 M USD |
2014-08-04 | Enumeral Biomedical | Montrose Capital Partners investment in Post-IPO Equity - Enumeral Biomedical | 21.5 M USD |
More informations about "Montrose Capital Partners"
Montrose Capital Partners - Crunchbase Investor …
Montrose Capital Partners invests in seed to post-IPO equity stages, focusing on biotechnology, healthcare, and medical devices, with a geographical focus in …See details»
Montrose Capital Partners investment portfolio
Apr 18, 2022 Montrose Capital Partners General Information Company Description. Founded in 2001, Montrose Capital Partners is a venture capital …See details»
Montrose Capital Partners - Venture Capital Investor - Tracxn
Apr 11, 2025 Co-investors of Montrose Capital Partners. Over the past . 14 years, 98 investors have co-invested in Montrose Capital Partners's portfolio companies.. This includes funds and …See details»
Montrose Capital Partners – Investors Database - Unicorn Nest
This organization was formed by Mark Tompkins. The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Montrose Capital Partners, startups are often financed by …See details»
Montrose Capital Partners - Portfolio, Partners, Reviews, News
Oct 26, 2023 Montrose Capital is a privately held company focused on identifying Public Markets Venture Capital investment opportunities. Through its partners, Montrose primarily invests in …See details»
Our Portfolio - Montrose Capital Partners
2 days ago Thank you for contacting us to learn more about Montrose Capital Partners.See details»
Montrose Capital Partners · 518 17th Street, Suite 940, Denver, CO …
Montrose Capital Partners (Entity #20061276908) is a DLLC in Denver, Colorado registered with the Colorado Department of State (CDOS). The entity was formed on July 7, 2006 in the …See details»
Montrose Capital Partners - CB Insights
Jun 14, 2018 The financing also included an investment from Montrose Capital Partners. The offering was exempt from registration under Section 4(a)(2) of the United States Securities Act …See details»
Board member @ Montrose Capital Partners - Crunchbase
Primary Organization . Montrose Capital Partners . Location New York, New York, United States; Regions Greater New York Area, East Coast, Northeastern US; ... Mark Tompkins is the …See details»
Montrose - Nästa nivå för dina investeringar
Montrose är ett helägt dotterbolag till DNB Carnegie Holding AB och agerar som ombud för DNB Carnegie Investment Bank AB, som är under tillsyn av …See details»
Montrose Capital Partners - Crunchbase
Montrose Capital is a privately held investment company focused on Public Markets Venture Capital. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... Companies …See details»
Montrose Capital Partners - Investments, Portfolio & Company Exits
Montrose Capital Partners 's most notable exits include Compass Therapeutics, Inc., Odyssey Semiconductor Technologies, and ViewRay. Montrose Capital Partners has acquired Amesite …See details»
Montrose Capital Partners - Contacts, Employees, Board Members ...
Montrose Capital is a privately held investment company focused on Public Markets Venture Capital. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... Montrose …See details»
Compass Therapeutics – Montrose Capital Partners
2 days ago CEO: Thomas J. Schuetz, M.D., Ph.D.Headquarters: Cambridge, MassachusettsURL: www.compasstherapeutics.comJune 2020APO Financing: …See details»
Montrose Capital Partners - Updates, News, Events, Signals
Montrose Capital is a privately held investment company focused on Public Markets Venture Capital. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
DCM Group, a Thrust Capital Partners portfolio company
2 days ago MONTREAL, June 4, 2025 /CNW/ - DCM Group Inc. ("DCM") is pleased to announce the acquisition of Metcor Inc., a Quebec-based company specializing in metal heat …See details»
Aerpio Therapeutics – Montrose Capital Partners
May 30, 2025 CEO: Joseph Gardner Headquarters: Cincinnati, Ohio URL: www.aerpio.com March 2017 APO Financing: $40,500,000 Trading Venue: NASDAQ CM (ARPO) Aerpio …See details»
Perfect Moment - Montrose Capital Partners
May 28, 2025 Headquarters: London, England URL: www.perfectmoment.com March 2021 Bridge Financing: $10,000,000 Trading Venue: NYSE American (PMNT) Perfect Moment was …See details»
Aeluma – Montrose Capital Partners
May 30, 2025 CEO: Jonathan Klamkin Headquarters: Goelta, California URL: www.aeluma.com July 2021 APO Financing: $8,000,000 Trading Venue: OTCQB (ALMU) Aeluma develops …See details»
Pieris Pharmaceuticals, Inc – Montrose Capital Partners
2 days ago CEO: Stephen S. Yoder, J.D. Headquarters: Boston, Massachusetts URL: www.pieris.com December 2014 APO Financing: $13,600,000 Trading Venue: NASDAQ CM …See details»